bendamustine hydrochloride plus rituximab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for bendamustine hydrochloride plus rituximab, covering 2014-04-28 to 2014-04-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of Bendamustine Hydrochloride and Rituximab (BR) Compared With R-CVP or R-CHOP in the First-Line Treatment of Patients With Advanced Indolent Non-Hodgkin's Lymphoma (NHL) or Mantle Cell Lymphoma (MCL) - Referred to as the BRIGHT Study [Phase 3]